Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

The company's immunology portfolio, led by Skyrizi and Rinvoq, continues to thrive despite Humira's patent expiration, ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

Martin Dreyling, MD, discusses how the safety and efficacy results from the TRIANGLE study in mantle cell lymphoma differ from prior expectations.

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

JNJ-2056 is under clinical development by Johnson & Johnson Innovative Medicine and currently in Phase II for Alzheimer's Disease.

JNJ-2056 is under clinical development by Johnson & Johnson Innovative Medicine and currently in Phase II for Tauopathies.

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

INR:4497. blackjack classic standard limit free spins Moderna launches development of updated COVID-19 vaccine for COVID-19 ...

Bugs Bunny Funko Pop A number of licensed pharmacists were investigated for hanging their certificates and their certificates were revoked New CRIS ...